Skip to main content

Study M731

Study name

Du Y 2021

Title

Plasma metabolites were associated with spatial working memory in major depressive disorder

Overall design

The aim of this study was to identify abnormal metabolites in major depressive disorder (MDD) by metabolomics and to explore the association between differential metabolites and neurocognitive dysfunction. Plasma samples from 53 MDD patients (MDD group) and 83 sex-, gender-, BMI-matched healthy controls (control group) were collected. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) system was used to detect metabolites in those samples.

Study Type

Type1;

Data available

Unavailable

Organism

Human;

Categories of depression

Depressive disorder; Depression; Depression;

Criteria for depression

DSM-IV diagnosed MDD

Sample size

136

Tissue

Peripheral; Blood; Plasma;

Platform

MS-based; LC-MS: Vanquish UHPLC system (Thermo Fisher) and an Orbitrap Q Exactive HF-X mass spectrometer (Thermo Fisher);

PMID

33663067

DOI

10.1097/MD.0000000000024581

Citation

Du Y, Wei J, Yang X, et al. Plasma metabolites were associated with spatial working memory in major depressive disorder. Medicine. 2021 Feb 26;100(8):e24581.

Metabolite

L-gamma-glutamyl-L-leucine;

Valeric acid;

Enkephalin L;